Evidence map›Paper›PMID 24567914›Full record

ReviewFrontiers in oncology2014

Regulation of Mouse Retroelement MuERV-L/MERVL Expression by REX1 and Epigenetic Control of Stem Cell Potency.

Jon Schoorlemmer, Raquel Pérez-Palacios, María Climent, Diana Guallar, Pedro Muniesa

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Retrotransposon renaissance in early embryos.Trends in genetics : TIG · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Minor Splicing FactorsInternational journal of molecular sciences · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jon SchoorlemmerRegenerative Medicine Program, Instituto Aragonés de Ciencias de la Salud , Zaragoza , Spain ; ARAID Foundation , Zaragoza , Spain.
Raquel Pérez-PalaciosRegenerative Medicine Program, Instituto Aragonés de Ciencias de la Salud , Zaragoza , Spain.
María ClimentDepartamento de Anatomía, Embriología y Genética Animal, Facultad de Veterinaria, Universidad de Zaragoza , Zaragoza , Spain.
Diana GuallarRegenerative Medicine Program, Instituto Aragonés de Ciencias de la Salud , Zaragoza , Spain.
Pedro MuniesaDepartamento de Anatomía, Embriología y Genética Animal, Facultad de Veterinaria, Universidad de Zaragoza , Zaragoza , Spain.
Instituto Aragonés de Ciencias de la Salud · ESUniversidad de Zaragoza · ESFundacion Agencia Aragonesa para la Investigacion y el Desarrollo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About half of the mammalian genome is occupied by DNA sequences that originate from transposable elements. Retrotransposons can modulate gene expression in different ways and, particularly retrotransposon-derived long terminal repeats, profoundly shape expression of both surrounding and distant genomic loci. This is especially important in pre-implantation development, during which extensive reprograming of the genome takes place and cells pass through totipotent and pluripotent states. At this stage, the main mechanism responsible for retrotransposon silencing, i.e., DNA methylation, is inoperative. A particular retrotransposon called muERV-L/MERVL is expressed during pre-implantation stages and contributes to the plasticity of mouse embryonic stem cells. This review will focus on the role of MERVL-derived sequences as controlling elements of gene expression specific for pre-implantation development, two-cell stage-specific gene expression, and stem cell pluripotency, the epigenetic mechanisms that control their expression, and the contributions of the pluripotency marker REX1 and the related Yin Yang 1 family of transcription factors to this regulation process.

Indexed as

developmental potentialembryonic stem cellsMERVLREX1/ZFP42two-cell state

Identifiers

PMID24567914
PMCPMC3915180
OpenAlexW2126091903

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.